Addressing the rise of multiple myeloma in Rwanda
Dr Van Vuurden talks to ecancertv at Children with Cancer UK’s workshop on Drug Delivery in Paediatric Brain Tumours in London, UK.
In the interview he discusses how nanotechnologies may be used to help deliver therapeutic drugs directly into the brainstem of children suffering from diffuse intrinsic pontine glioma (DIPG).
Due to its location DIPG is a particularly difficult paediatric tumour to treat and there are few options available.
Several approaches are being investigated that could have a big impact on the disease in the future.
One of these is delivering very small gas microbubbles that vibrate when focal ultrasound is applied to open up the blood-brain barrier enough so that a therapeutic agent could enter the brain.
Addressing the rise of multiple myeloma in Rwanda
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
GIST tumours and soft tissue sarcomas
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Uncommon genetic aberrations NTRK, RET, NRG
EHA 2024: Multiple myeloma roundup
Relapsed refractory multiple myeloma
Updates on triple-negative breast cancer and immunotherapy
Pembrolizumab benefits patients with brain metastases